e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Cystic fibrosis (adults and children): new basic and clinical physiology research
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Tracking disease progression in cystic fibrosis using bronchiectasis, trapped air and quality of life
L. Tepper, E. Utens, D. Caudri, A. Quittner, H. Tiddens (Rotterdam, Netherlands; Miami, United States Of America)
Source:
Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research
Session:
Cystic fibrosis (adults and children): new basic and clinical physiology research
Session type:
Poster Discussion
Number:
1450
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Tepper, E. Utens, D. Caudri, A. Quittner, H. Tiddens (Rotterdam, Netherlands; Miami, United States Of America). Tracking disease progression in cystic fibrosis using bronchiectasis, trapped air and quality of life. Eur Respir J 2012; 40: Suppl. 56, 1450
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Impact of bronchiectasis and trapped air on quality of life and exacerbations in cystic fibrosis
Source: Eur Respir J 2013; 42: 371-379
Year: 2013
Understanding patients’ experience of living with non-cystic fibrosis bronchiectasis
Source: Annual Congress 2013 –Aspects of physiotherapy in various clinical conditions and settings
Year: 2013
Treatment of advanced cystic fibrosis lung disease and end of life decisions
Source: School Course 2013 - Cystic Fibrosis
Year: 2013
Home versus hospital treatment of acute cystic fibrosis pulmonary exacerbations – Is quality of life really better at home?
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Patient reported quality of life in advanced cystic fibrosis (CF) lung disease assessed for lung transplantation
Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous
Year: 2008
Early detection of pulmonary exacerbations in children with cystic fibrosis by electronic home monitoring of symptoms and lung function
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016
Pulmonary function, inflammation, exercise capacity and quality of life in cystic fibrosis
Source: Eur Respir J 2001; 17: 712-715
Year: 2001
Monitoring early lung disease in cystic fibrosis: where are we now?
Source: Breathe 2014; 10: 34-47
Year: 2014
Improving airway clearance in cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 169-187
Year: 2014
Factors affecting progression of lung disease among patients with cystic fibrosis
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019
Health-related quality of life and health status among patients with sarcoidosis, chronic obstructive pulmonary disease and interstitial lung disease
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018
Quality of life of patients with idiopathic pulmonary fibrosis (IPF) - What can the Australian IPF registry tell us?
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015
Quality of life in children with cystic fibrosis and asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 342s
Year: 2002
Early cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 77-87
Year: 2014
Do causes influence clinical, functional and quality of life aspects on patients with bronchiectasis not associated with cystic fibrosis?
Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions
Year: 2019
Effect of nintedanib on cough and health related quality of life in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
The burden of idiopathic pulmonary fibrosis reported by patients and carers in Ireland
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Global impact of bronchiectasis and cystic fibrosis
Source: Breathe 2016; 12: 222-235
Year: 2016
Evolution of lung clearance index during the first year of life in cystic fibrosis
Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis
Year: 2021
Inflammation and infection in infants with cystic fibrosis is associated with changes in lung function in the first year of life
Source: Annual Congress 2008 - Respiratory physiology in health and disease
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept